Pharma4ever Engineering ApS: Financial statements 2023
CVR: 41699477
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma4ever Engineering ApS (CVR 41699477) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 14,766,812 and a net result of DKK 3,019,912 compared with DKK 670,558 the year before. That is an increase of 285.1% compared with the year before. Equity in the 2023 report amounted to DKK 3,158,354. The solvency ratio was 38.2%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 14,766,812
- Profit/Loss
- DKK 3,019,912
- Equity
- DKK 3,158,354
- Total Assets
- DKK 8,260,898
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 14.8 mio. | 3 mio. | 3.2 mio. | 11 |
| 2022 | - | 3.8 mio. | 671 t. | 788 t. | 3 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma4ever Engineering ApS has published its annual report for 2022. Gross profit came to DKK 3,834,944, and the net result was DKK 670,558.
About Pharma4ever Engineering ApS
Pharma4ever Engineering ApS is a Danish company of the type Anpartsselskab based in Tikøb, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The management consists of Jonas Mortensen Højslet. The company is owned by BHP Holding ApS, Andresen Holding af 29. maj 2015 ApS and Finished Goods Engineering ApS. In 2025, the company reported a gross profit of DKK 12,586,113 and a net result of DKK 2,325,191 compared with DKK 1,037,826 the year before. Equity in the 2025 report amounted to DKK 2,365,191.